CAHE Conducts New Study to Examine Patient Preference for Shield, Guardant Health’s Blood Test to Screen for Colorectal Cancer
CAHE is excited to conduct the study, Understanding Patient Preference on Colorectal Cancer Screening Options (U-Screen), with patients receiving care at Federally Qualified Health Centers (FQHC) who fail to complete guideline recommended screening will have the option to complete their screening with a Shield blood test. Shield test performance was recently clinically validated by the ECLIPSE Study – one of the largest cancer screening studies of its kind – and achieved 83% sensitivity for the detection of colorectal cancer.
Çok yararlı bi yazı olmuş hocam teşekkür ederim .Sizin yazılarınızı beğenerek okuyorum elinize sağlık.